Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response

Infection
José BordónJulio Ramirez

Abstract

Further examination of clinical outcomes and inflammatory response of bacteremic pneumococcal community-acquired pneumonia (CAP) is of great interest to enhance the care of patients with pneumococcal CAP. This is a secondary analysis of the Community Acquired Pneumonia Organization (CAPO) to compare the time to clinical stability (TCS), length of hospital stay (LOS), and in-hospital mortality of hospitalized pneumococcal CAP patients with and without bacteremia. To measure the effect of bacteremia in pneumococcal CAP patients on outcomes, we modeled all-cause in-hospital mortality using a Poisson regression model, and TCS and LOS using Cox proportional hazards models. Adjusted multivariate regression models were also used to predict the probability of occurrence of each of the study outcomes. To investigate the inflammatory response, we measured the plasma levels of pro- and anti-inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1rα, IL-6, IL-8, IL-10], inflammatory biomarkers [C-reactive protein (CRP), pro-calcitonin (PCT), and B-type natriuretic peptide (BNP)], and peripheral blood neutrophil responses in 10 patients, 4 bacteremic and 6 non-bacteremic pneumococcal CAP, upon admission and every other day ...Continue Reading

References

Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Mar 9, 2000·The New England Journal of Medicine·J P NuortiR F Breiman
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanAmerican Thoracic Society
Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jae-Hoon SongAsian Network for Surveillance of Resistant Pathogens Study Group
Oct 6, 2005·Journal of Leukocyte Biology·Forest R SheppardChristopher C Silliman
Mar 3, 2007·American Journal of Respiratory and Critical Care Medicine·Forest W ArnoldCommunity-Acquired Pneumonia Organization (CAPO) Investigators
Jul 14, 2007·Trends in Immunology·Niels BorregaardKim Theilgaard-Mönch
Feb 27, 2008·Journal of Internal Medicine·M Christ-CrainC Mueller
May 30, 2008·The European Respiratory Journal·C Garcia-VidalF Gudiol
Sep 20, 2008·PLoS Pathogens·Ying-Jie LuRichard Malley
Nov 4, 2010·Molecular Medicine·Jochen Grommes, Oliver Soehnlein
Jul 12, 2013·The New England Journal of Medicine·Marie R GriffinCarlos G Grijalva
Nov 13, 2013·Journal of Critical Care·José Manuel PereiraJosé Artur Paiva
Aug 7, 2014·BMC Pulmonary Medicine·Alberto CapelasteguiPedro P España

Citations

Sep 2, 2016·Current Opinion in Critical Care·Charles Feldman, Ronald Anderson
Nov 18, 2016·PloS One·Luis F ReyesCarlos J Orihuela
Feb 22, 2018·Current Opinion in Pulmonary Medicine·Charles Feldman, Ronald Anderson
Jan 18, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard G WunderinkCarlos G Grijalva
Jan 17, 2019·Medical Sciences : Open Access Journal·Nicolò Maria VanoniFrancesco Blasi
Oct 24, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Lessandra MichelinMaria Carolina Gullo
Oct 3, 2018·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Ying WangLiying Wang
Jun 27, 2019·Expert Review of Respiratory Medicine·Jerry S Zifodya, Kristina Crothers
Jul 13, 2019·The Journal of Infection·Stefano AlibertiGLIMP investigators
Jun 5, 2021·Respiratory Medicine·Ahuva AverinStephen I Pelton

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.